PHarmaceutical tech@2x
  • News

    Most Read

    • Merck to discontinue development of two Covid-19 vaccine candidates
    • Moderna’s Covid-19 vaccine effective against emerging variants in new study
    • Elasmogen identifies potential vaccine candidates to fight Covid-19

    Most Recent

    Drug Development

    Merck to discontinue development of two Covid-19 vaccine candidates

    26 Jan 2021
  • Analysis

    Sections

    • Features
    • Comment
    • Projects

    Most Read

    • Genomics: Technology Trends
    • A new hope for slowing disability in MS
    • Covid-19 vaccine rollouts begin worldwide – leading macroeconomic influencers

    Most Recent

    Genomics: Technology Trends

    25 Jan 2021
  • Sectors

    Sections

    • Clinical Trials
    • Supply Chain
    • Drug Development
    • Manufacturing
    • Diseases
      • Cardiovascular
      • Central Nervous System
      • Immunology
      • Infectious Diseases
      • Oncology
      • Respiratory

    Most Read

    • GlobalData Epidemiologist Report: Global Covid cases near 100 million – ‘long haul’ symptoms can last more than six months
    • Genomics: Regulatory Trends
    • Merck to discontinue development of two Covid-19 vaccine candidates

    Most Recent

    GlobalData Epidemiologist Report: Global Covid cases near 100 million – ‘long haul’ symptoms can last more than six months

    26 Jan 2021
  • Themes
  • Deals

    Most Read

    • Lilly acquires biotechnology company Prevail Therapeutics for $1.04bn
    • Exploring dark antigens: Enara and Boehringer Ingelheim sign oncology partnership
    • Thermo Fisher Scientific acquires Novasep’s Henogen for $874.5m

    Most Recent

    deal

    Lilly acquires biotechnology company Prevail Therapeutics for $1.04bn

    25 Jan 2021
  • Companies

    Sections

    • Company A-Z
    • Company Categories
    • Product & Services
    • Company Releases
    • White Papers
    • Videos

    Most Read

    • CPL
    • TOTE® SYSTEMS
    • RSD

    Most Recent

    Drug Development

    CPL

    25 Jan 2021
  • Magazine
  • Events
Menu
  • News
  • Analysis
    • Features
    • Comment
    • Projects
  • Investment
  • Sectors
    • Clinical Trials
    • Supply Chain
    • Drug Development
    • Manufacturing
    • Diseases
      • Cardiovascular
      • Central Nervous System
      • Immunology
      • Infectious Diseases
      • Oncology
  • Deals
  • US Election
  • Disruption
  • Coronavirus
Partners
  • Accelerating Clinical Trials
  • Powder Handling
  • Simplifying Clinical Trials
Tools
  • Companies
    • Company A-Z
    • Company Categories
    • Product & Services
    • Company Releases
    • White Papers
    • Videos
  • Reports
  • Awards
  • Events
  • Magazine
The Company
  • About Us
  • Contact Us
  • Advertise With Us
  • Visit GlobalData
  • Login
  • Register
  • Login
  • Register
US pharma industry sees a drop of 22.2% in deal activity in July 2019

US pharma industry sees a drop of 22.2% in deal activity in July 2019

23 August 2019
Pharma industry deals in July 2019 total $4.57bn globally

Pharma industry deals in July 2019 total $4.57bn globally

21 August 2019
China’s pharma industry sees a drop of 28.1% in deal activity in Q2 2019

China’s pharma industry sees a drop of 28.1% in deal activity in Q2 2019

16 July 2019
North America’s pharma industry sees a drop of 10.3% in deal activity in Q2 2019

North America’s pharma industry sees a drop of 10.3% in deal activity in Q2 2019

16 July 2019
Europe’s pharma industry sees a rise of 1.2% in deal activity in Q2 2019

Europe’s pharma industry sees a rise of 1.2% in deal activity in Q2 2019

16 July 2019
Pharma industry M&A deals in Q2 2019 total $114.8bn globally

Pharma industry M&A deals in Q2 2019 total $114.8bn globally

16 July 2019
Pharma industry venture financing deals in Q2 2019 total $2.72bn in US

Pharma industry venture financing deals in Q2 2019 total $2.72bn in US

16 July 2019
Pharma industry deals in Q2 2019 total $121.51bn globally

Pharma industry deals in Q2 2019 total $121.51bn globally

16 July 2019
Pharma industry private equity deals in Q2 2019 total $2.98bn globally

Pharma industry private equity deals in Q2 2019 total $2.98bn globally

16 July 2019
Pharma industry venture financing deals in Q2 2019 total $3.72bn globally

Pharma industry venture financing deals in Q2 2019 total $3.72bn globally

16 July 2019

Latest News

Drug Development

Merck to discontinue development of two Covid-19 vaccine candidates

26 Jan 2021
Drug Development

Moderna’s Covid-19 vaccine effective against emerging variants in new study

25 Jan 2021
Drug Development

Elasmogen identifies potential vaccine candidates to fight Covid-19

25 Jan 2021
Technology

Telemedicine to benefit the most from remote patient monitoring tools: Poll

25 Jan 2021

Company A-Z

View All

Company Releases

View All

White Papers

View All

Videos

View All
logo-horizontal

Powered by Pharma Tech Logo

  • About Us
  • Editorial Approach
  • Contact Us
  • Terms & Conditions
  • Privacy Policy

© Copyright 2021 Verdict Media Limited.

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more